News

Telavancin is a bactericidal, once-daily injectable investigational antibiotic with a multifunctional mechanism of action. Telavancin was discovered by Theravance in a research program dedicated to finding new antibiotics

Prior to joining Aragon Surgical, Mr Snow served as director of sales and marketing at Medlogics, a cardiology device company. Prior to Medlogics, Mr Snow served at Rubicor

AstraZeneca markets Prilosec for the treatment of duodenal/gastric ulcers and gastro-esophageal reflux disease. The company’s versions of generic Prilosec (including previously approved and marketed 10mg and 20mg capsules)

This patent, exclusively licensed from the Massachusetts General Hospital, provides FluoroPharma with additional patent claims that cover imaging of atherosclerotic plaque inflammation and rupture. Kundakovic, president of FluoroPharma,

Adjusted earnings per share (EPS), excluding stock option expense and certain other expenses, was $1.06 for the fourth quarter of 2008, an increase of 6% compared to $1

According to the company, the clearance enables it to move forward with the world’s first study of a human embryonic stem cell (hESC)-based therapy in man. Geron plans

Under the collaboration, Corgenix will work with Battelle on biodefense related projects and programs. Under the terms of the collaboration agreement, Corgenix will provide biodefense project support to

Omeprazole delayed-release (DR) capsules are indicated for the treatment of peptic ulcers and gastroesophageal reflux disease. Mylan Pharmaceuticals is shipping this product immediately.

Mr Perez is currently the executive vice president and COO at Cubist Pharmaceuticals, and is responsible for commercial operations, business development, technical operations, the Cubicin development team and